Skip to content

UnitedHealth

US · UNH #44 by market cap Listed 1984
418.27 +11.39 +2.80%
Live - 5344 symbols - heartbeat 557s ago · 2026-10-20 10:50

Analyst consensus 21 analysts

Buy
Avg price target 485.00 +16.0%
Price target rangecurrent 418.27
Low402.00
Avg485.00
High529.00
Buy 81% Hold 19% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-10-09 TD Cowen -- Hold 402.00
2026-10-09 Piper Sandler -- Buy 463.00
2026-10-08 Erste Group -- Hold --
2026-10-07 RBC Capital -- Buy 478.00
2026-10-05 Bernstein -- Buy 512.00
2026-10-02 Goldman Sachs -- Buy 490.00
2026-09-15 Wells Fargo -- Buy 526.00
2026-09-14 UBS -- Buy 490.00
2026-09-14 Evercore -- Buy 480.00
2026-09-10 Barclays -- Buy 441.00
2026-09-09 Wells Fargo -- Buy 526.00
2026-09-09 Bernstein -- Buy 512.00
2026-09-04 Bernstein -- Buy 512.00
2026-08-28 Bernstein -- Buy 512.00
2026-08-27 Erste Group -- Hold --
2026-08-14 Bernstein -- Buy 512.00
2026-08-12 Bernstein -- Buy 512.00
2026-08-03 Deutsche Bank -- Hold --
2026-07-21 Bernstein -- Buy 512.00
2026-07-21 Mizuho Securities -- Buy 493.00
2026-07-21 J.P. Morgan -- Buy 516.00
2026-07-19 TD Cowen -- Hold 430.00
2026-07-17 Wells Fargo -- Buy 526.00
2026-07-17 Argus Research -- Buy 470.00
2026-07-17 UBS -- Buy 490.00

Quant vs Street three independent views, side by side

Momentum strategy signal
Hold
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Price target trend monthly average, last 3 years

✦ Quant Analyst Revision Trend how this is computed

Improving
4 1
■ Upgrades■ Downgrades
  • 4 upgrades vs 1 downgrade among tracked analyst rating changes.
  • The single most recent change was actually a downgrade (Erste Group moved from Buy to Hold on 2026-08-27), though the broader window skews toward upgrades.

Recent rating changes

DateFirmChangeTarget
2026-08-27 Erste Group Buy → Hold --
2026-07-16 Baird Sell → Hold 453.00
2026-06-24 BofA Securities Hold → Buy 475.00
2026-04-27 Erste Group Hold → Buy --
2026-04-07 HSBC Sell → Hold 300.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-13 -- ±6.47% -0.20% (in line)
2026/Q2 2026-07-16 -- ±5.90% +1.16% (in line)
2026/Q1 2026-04-21 -- ±5.61% +6.96% (beat)
2025/Q4 2026-01-27 -- ±5.95% -19.61% (beat)
2025/Q3 2025-10-28 -- ±5.84% +0.51% (in line)
2025/Q2 2025-07-29 -- ±8.05% -7.46% (in line)
2025/Q1 2025-04-17 -- ±5.01% -22.38% (beat)
2024/Q4 2025-01-16 -- ±4.43% -6.04% (beat)
2024/Q3 2024-10-15 -- ±4.36% -8.11% (beat)
2024/Q2 2024-07-16 -- ±4.72% +6.50% (beat)
2024/Q1 2024-04-16 -- ±5.07% +5.22% (beat)
2023/Q4 2024-01-12 -- ±3.01% -3.37% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-10-20 10:50:14 · For reference only, not investment advice and not tailored to your situation.

UnitedHealth discussion 1 comments

  1. medical cost ratio finally stabilizing after a rough stretch, this name went from market darling to cautionary tale faster than almost anything I’ve watched in healthcare.

Add a comment